Roe Justin W G, Drinnan Michael J, Carding Paul N, Harrington Kevin J, Nutting Christopher M
Head and Neck Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, United Kingdom; The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, United Kingdom.
Institute of Cellular Medicine, University of Newcastle upon Tyne, NE1 7RU, United Kingdom.
Oral Oncol. 2014 Dec;50(12):1182-7. doi: 10.1016/j.oraloncology.2014.09.009. Epub 2014 Oct 14.
Swallowing can be significantly affected during and following radiotherapy for head and neck cancer (HNC). The purpose of this study was to understand: (1) the trajectory of swallowing recovery following parotid-sparing intensity-modulated radiotherapy (IMRT) and (2) overall physical and social-emotional wellbeing and how patients prioritise swallowing following treatment.
Sixty-one HNC patients completed questionnaires as part of a prospective study exploring patient-reported swallowing outcomes following parotid-sparing IMRT. Participants were asked to complete the M.D. Anderson Dysphagia Inventory (MDADI) and University of Washington Quality of Life Questionnaire (UW-QoL) v.04 before treatment and 3, 6 and 12months after treatment. Given the rise in human papilloma virus (HPV) and associated oropharyngeal cancers, we completed a sub analysis of the data in those participants.
There was a significant reduction in the MDADI composite scores 3months after completion of treatment. Improvements were observed by 12months, however, scores did not recover to baseline. The recovery in physical function was limited in comparison to social-emotional recovery at 12months. When oropharyngeal cancer scores were analysed, there was not a substantial difference to the whole group results. There was a shift in priorities following treatment. Swallowing was highlighted as a concern by 44% of HNC patients up to 12months after treatment with swallowing-related factors (saliva, taste and chewing) rated highly.
Patient reported swallowing outcomes were significantly affected from baseline to all follow-up time points and remained a priority concern at 12months following treatment. Overall social-emotional functioning does improve, suggesting that patients have the potential to adapt to their "new normal" following IMRT for HNC.
头颈部癌(HNC)放疗期间及放疗后吞咽功能可能会受到显著影响。本研究的目的是了解:(1)腮腺保留调强放疗(IMRT)后吞咽功能恢复的轨迹;(2)整体身体和社会情感健康状况,以及患者在治疗后如何将吞咽功能列为优先事项。
61例HNC患者完成了问卷调查,作为一项前瞻性研究的一部分,该研究旨在探索腮腺保留IMRT后患者报告的吞咽结果。参与者被要求在治疗前以及治疗后3个月、6个月和12个月完成MD安德森吞咽障碍量表(MDADI)和华盛顿大学生活质量问卷(UW-QoL)第4版。鉴于人乳头瘤病毒(HPV)及相关口咽癌的发病率上升,我们对这些参与者的数据进行了亚组分析。
治疗完成后3个月,MDADI综合评分显著降低。到12个月时观察到有所改善,然而,评分未恢复到基线水平。与12个月时的社会情感恢复相比,身体功能的恢复有限。分析口咽癌评分时,与整个组的结果没有实质性差异。治疗后优先事项发生了转变。44%的HNC患者在治疗后12个月内将吞咽问题列为关注点,与吞咽相关的因素(唾液、味觉和咀嚼)被高度评价。
患者报告的吞咽结果从基线到所有随访时间点均受到显著影响,并且在治疗后12个月仍然是一个优先关注的问题。整体社会情感功能确实有所改善,这表明HNC患者在接受IMRT治疗后有潜力适应其“新常态”。